Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
Also known as: Transitional cell cancer of the renal pelvis and ureter recurrent / Renal pelvis and ureter transitional cell cancer recurrent / Renal pelvis and ureteric cancer recurrent transitional cell / Renal pelvis and ureteral cancer transitional cell recurrent / Renal pelvis and ureteric cancer transitional cell recurrent
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00958 | Carboplatin | 1 | Completed | 1 |
DB15631 | Edodekin alfa | 1 | Completed | 1 |
DB15721 | Natural Killer Cell | 1 | Completed | 1 |
DB01229 | Paclitaxel | 1 | Completed | 1 |
DB00072 | Trastuzumab | 1 | Completed | 1 |
DB08885 | Aflibercept | 2 | Completed | 1 |
DB01169 | Arsenic trioxide | 2 | Completed | 1 |
DB04456 | Arsenous acid | 2 | Completed | 1 |
DB00188 | Bortezomib | 2 | Completed | 1 |
DB16741 | Bortezomib D-mannitol | 2 | Completed | 1 |
DB00958 | Carboplatin | 2 | Completed | 1 |
DB00515 | Cisplatin | 2 | Completed | 1 |
DB00997 | Doxorubicin | 2 | Completed | 1 |
DB00099 | Filgrastim | 2 | Completed | 1 |
DB00317 | Gefitinib | 2 | Completed | 1 |
DB00441 | Gemcitabine | 2 | Completed | 3 |
DB04845 | Ixabepilone | 2 | Completed | 1 |
DB01229 | Paclitaxel | 2 | Completed | 2 |
DB03010 | Patupilone | 2 | Completed | 1 |
DB06589 | Pazopanib | 2 | Completed | 1 |
DB00019 | Pegfilgrastim | 2 | Completed | 1 |
DB00398 | Sorafenib | 2 | Completed | 1 |
DB00398 | Sorafenib | 2 | Terminated | 1 |
DB00072 | Trastuzumab | 2 | Completed | 1 |
DB00072 | Trastuzumab | 2 | Terminated | 1 |
DB02546 | Vorinostat | 2 | Terminated | 1 |